Lipoprotein Subclass Abnormalities and Incident Hypertension in Initially Healthy Women
Author:
Affiliation:
1. Divisions of Preventive Medicine and
2. Department of Medicine, University Hospital, Basel, Switzerland
3. LipoScience, Inc, Raleigh, NC
4. Division of Cardiovascular Diseases, Brigham and Women's Hospital, Boston, Massachusetts
Abstract
Funder
National Heart, Lung, and Blood Institute
National Cancer Institute
Donald W. Reynolds Foundation
Doris Duke Charitable Foundation
Novartis
University of Basel
Publisher
Oxford University Press (OUP)
Subject
Biochemistry (medical),Clinical Biochemistry
Link
http://academic.oup.com/clinchem/article-pdf/57/8/1178/32654923/clinchem1178.pdf
Reference29 articles.
1. Heart disease and stroke statistics–2011 update: a report from the American Heart Association;Roger;Circulation,2011
2. Banting lecture 1988;Reaven;Role of insulin resistance in human disease. Diabetes,1988
3. A prospective study of plasma lipid levels and hypertension in women;Sesso;Arch Intern Med,2005
4. Dyslipidemia and the risk of incident hypertension in men;Halperin;Hypertension,2006
5. Risk factors for arterial hypertension in adults with initial optimal blood pressure: the strong heart study;de Simone;Hypertension,2006
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical Adenomas;The Journal of Clinical Endocrinology & Metabolism;2024-06-13
2. Fasting Triglycerides in the Upper Normal Range Are Independently Associated with an Increased Risk of Diabetes Mortality in a Large Representative US Population;Journal of Cardiovascular Development and Disease;2024-04-21
3. Circulating metabolic biomarkers and risk of new-onset hypertension: findings from the UK Biobank;Journal of Hypertension;2024-02-19
4. Major lipids and lipoprotein levels and risk of blood pressure elevation: a Mendelian Randomisation study;eBioMedicine;2024-02
5. Triglyceride, an Independent Risk Factor for New-Onset Hypertension: A Perspective;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3